Shu D - Search Results

1

Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.

Xu C, Haque F, Jasinski DL, Binzel DW, Shu D, Guo P. Xu C, et al. Among authors: shu d. Cancer Lett. 2018 Feb 1;414:57-70. doi: 10.1016/j.canlet.2017.09.043. Epub 2017 Oct 5. Cancer Lett. 2018. PMID: 28987384 Free PMC article. Review.

2

Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

Shu Y, Haque F, Shu D, Li W, Zhu Z, Kotb M, Lyubchenko Y, Guo P. Shu Y, et al. Among authors: shu d. RNA. 2013 Jun;19(6):767-77. doi: 10.1261/rna.037002.112. Epub 2013 Apr 19. RNA. 2013. PMID: 23604636 Free PMC article.

3

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Shu Y, Pi F, Sharma A, Rajabi M, Haque F, Shu D, Leggas M, Evers BM, Guo P. Shu Y, et al. Among authors: shu d. Adv Drug Deliv Rev. 2014 Feb;66:74-89. doi: 10.1016/j.addr.2013.11.006. Epub 2013 Nov 22. Adv Drug Deliv Rev. 2014. PMID: 24270010 Free PMC article. Review.

4

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.

Shu D, Li H, Shu Y, Xiong G, Carson WE 3rd, Haque F, Xu R, Guo P. Shu D, et al. Among authors: shu y. ACS Nano. 2015 Oct 27;9(10):9731-40. doi: 10.1021/acsnano.5b02471. Epub 2015 Sep 21. ACS Nano. 2015. PMID: 26387848 Free PMC article.

5

Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.

Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P. Binzel DW, et al. Among authors: shu d, shu y. Mol Ther. 2016 Aug;24(7):1267-77. doi: 10.1038/mt.2016.85. Epub 2016 Apr 29. Mol Ther. 2016. PMID: 27125502 Free PMC article.

6

Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.

Xu Y, Pang L, Wang H, Xu C, Shah H, Guo P, Shu D, Qian SY. Xu Y, et al. Among authors: shu d. Redox Biol. 2019 Feb;21:101085. doi: 10.1016/j.redox.2018.101085. Epub 2018 Dec 18. Redox Biol. 2019. PMID: 30584980 Free PMC article.

7

Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.

Yin H, Xiong G, Guo S, Xu C, Xu R, Guo P, Shu D. Yin H, et al. Among authors: shu d. Mol Ther. 2019 Jul 3;27(7):1252-1261. doi: 10.1016/j.ymthe.2019.04.018. Epub 2019 Apr 25. Mol Ther. 2019. PMID: 31085078 Free PMC article.

8

Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Shu Y, Cinier M, Shu D, Guo P. Shu Y, et al. Among authors: shu d. Methods. 2011 Jun;54(2):204-14. doi: 10.1016/j.ymeth.2011.01.008. Epub 2011 Feb 12. Methods. 2011. PMID: 21320601 Free PMC article. Review.

9

Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers.

Haque F, Shu D, Shu Y, Shlyakhtenko LS, Rychahou PG, Evers BM, Guo P. Haque F, et al. Among authors: shu d, shu y. Nano Today. 2012 Aug;7(4):245-257. doi: 10.1016/j.nantod.2012.06.010. Nano Today. 2012. PMID: 23024702 Free PMC article.

10

Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.

Shu Y, Shu D, Haque F, Guo P. Shu Y, et al. Among authors: shu d. Nat Protoc. 2013 Sep;8(9):1635-59. doi: 10.1038/nprot.2013.097. Epub 2013 Aug 1. Nat Protoc. 2013. PMID: 23928498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

689 results

Search Page

Filters